World's Best Scientists 2026 revealed!
Alexander M. Menzies

Alexander M. Menzies

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 88 13014 12250 425 415 469 34047

Alexander M. Menzies publications per year

The chart shows the history of publications by Alexander M. Menzies between 2010 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Alexander M. Menzies published across 16 years, from 2010 to 2025, averaging 46.7 papers a year. Output peaked at 260 publications in 2023. 104 of the 747 publications appeared in the last two years.

No. of publications
50 100 150 200 250
Bar chart. Horizontal axis: year, 2010 to 2025. Vertical axis: number of publications, 0 to 260. Peak 260 publications in 2023. 2010: 1 publication 2011: 3 publications 2012: 7 publications 2013: 12 publications 2014: 20 publications 2015: 18 publications 2016: 23 publications 2017: 31 publications 2018: 41 publications 2019: 51 publications 2020: 54 publications 2021: 71 publications 2022: 51 publications 2023: 260 publications 2024: 51 publications 2025: 53 publications
2010 2025

747 publications in total across all disciplines

View publications per year as a table
Alexander M. Menzies: publications per year, 2010 to 2025
Year Publications
2010 1
2011 3
2012 7
2013 12
2014 20
2015 18
2016 23
2017 31
2018 41
2019 51
2020 54
2021 71
2022 51
2023 260
2024 51
2025 53
Total 747
Download as CSV

Alexander M. Menzies publications per year - data summary

  • Alexander M. Menzies, a Medicine scholar from University of Sydney, has 747 publications recorded across 16 years, from 2010 to 2025.
  • The oldest publication on record dates to 2010 and the most recent to 2025.
  • The most productive year is 2023, with 260 publications.
  • The least productive year with any output is 2010, with 1 publication.
  • The rate of publication averages 46.7 papers per year over the whole span, or 46.7 per year counting only the 16 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 486 publications, 65% of the career total.
  • Split into equal eras - 2010-2015: 61 publications (10.2 per year); 2016-2021: 271 publications (45.2 per year); 2022-2025: 415 publications (103.8 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Alexander M. Menzies publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alexander M. Menzies sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 461–480 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 469 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751 469
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Alexander M. Menzies publication distribution in Medicine in 2026 - data summary

  • The chart plots the publication count of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 86 ranges running from 101–120 to 1,796+ publications.
  • Alexander M. Menzies, a Medicine scholar from University of Sydney, records 469 publications - the 52nd percentile of the discipline.
  • 52% of ranked Medicine scientists score the same or lower than Alexander M. Menzies, and about 48% score higher.
  • The median of the discipline falls in the 441–460 publications range, and Alexander M. Menzies ranks above the median.
  • The most crowded range is 341–360 publications, holding 922 scientists (5% of the field).
  • 64% of the field sits in the lowest quarter of the value range (up to 521–540 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,796 publications or more, 100 scientists in all (<1% of the field).

Alexander M. Menzies D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alexander M. Menzies sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 88–89 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970 88
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Alexander M. Menzies D-index placement in Medicine in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 75 ranges running from 70–71 to 217+ D-Index.
  • Alexander M. Menzies, a Medicine scholar from University of Sydney, records 88 D-Index - the 36th percentile of the discipline.
  • 36% of ranked Medicine scientists score the same or lower than Alexander M. Menzies, and about 64% score higher.
  • The median of the discipline falls in the 94–95 D-Index range, and Alexander M. Menzies ranks below the median.
  • The most crowded range is 82–83 D-Index, holding 1,027 scientists (5% of the field).
  • 70% of the field sits in the lowest quarter of the value range (up to 106–107 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 217 D-Index or more, 98 scientists in all (<1% of the field).

Overview

Alexander M. Menzies is affiliated with the University of Sydney in Australia. Their research primarily focuses on medicine with a strong emphasis on oncology, evidenced by 467 publications in this subfield.

Their work extends to related areas such as molecular biology, immunology, pulmonary and respiratory medicine, and epidemiology. The subfield publication counts are 122 for molecular biology, 97 for immunology, 30 for pulmonary and respiratory medicine, and 19 for epidemiology.

Menzies has contributed extensively to topics including cancer immunotherapy and biomarkers, with 384 publications. Other significant topics in their research portfolio include CAR-T cell therapy research (226 publications), cutaneous melanoma detection and management (212 publications), melanoma and MAPK pathways (184 publications), immunotherapy and immune responses (156 publications), brain metastases and treatment (40 publications), and cancer genomics and diagnostics (34 publications).

Frequent coauthors collaborating with Menzies include:

  • Georgina V. Long (250 joint publications)
  • Matteo S. Carlino (129 joint publications)
  • Richard A. Scolyer (128 joint publications)
  • Serigne Lo (92 joint publications)
  • Robyn P.M. Saw (76 joint publications)

Scholarly output by Menzies appears prominently in several leading journals. The most frequent publication venues are:

  • Journal of Clinical Oncology (62 publications)
  • Annals of Oncology (35 publications)
  • European Journal of Cancer (32 publications)
  • Cancer Research (18 publications)
  • Journal for ImmunoTherapy of Cancer (16 publications)

Recent representative publications by Menzies and collaborators include:

  • Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC), 2021, Nature Medicine
  • Cutaneous melanoma, 2023, The Lancet
  • Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma, 2021, Nature Medicine
  • Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial, 2022, Nature Medicine
  • Transcriptional downregulation of MHC class I and melanoma de-differentiation in resistance to PD-1 inhibition, 2020, Nature Communications

Best Publications

  • Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

    Daniel Y. Wang;Joe Elie Salem;Joe Elie Salem;Justine V. Cohen;Sunandana Chandra

  • Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma

    Georgina V. Long;Alexander M. Menzies;Adnan M. Nagrial;Lauren E. Haydu

  • Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

    Jarushka Naidoo;Xuan Wang;Xuan Wang;Xuan Wang;Kaitlin M. Woo;Kaitlin M. Woo;Tunc Iyriboz;Tunc Iyriboz

  • Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

    Georgina V Long;Victoria Atkinson;Serigne Lo;Shahneen Sandhu

  • Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

    Alexander M. Menzies;Alexander M. Menzies;D. B. Johnson;S. Ramanujam;V. G. Atkinson

  • Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

    Tuba N. Gide;Camelia Quek;Alexander M. Menzies;Annie T. Tasker

  • Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders

    Douglas B. Johnson;Ryan J. Sullivan;Patrick A. Ott;Matteo S. Carlino

  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

    Jennifer L. McQuade;Carrie R. Daniel;Kenneth R. Hess;Carmen Mak

  • BRAF inhibitor resistance mechanisms in metastatic melanoma; spectrum and clinical impact.

    Helen Rizos;Alexander M. Menzies;Gulietta M. Pupo;Matteo S. Carlino

  • Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma

    Alexander M. Menzies;Lauren E. Haydu;Lydia Visintin;Lydia Visintin;Lydia Visintin;Matteo S. Carlino;Matteo S. Carlino

  • PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.

    Jason Madore;Ricardo E. Vilain;Ricardo E. Vilain;Alexander M. Menzies;Hojabr Kakavand

  • Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

    Elisa A Rozeman;Alexander M Menzies;Alexander C J van Akkooi;Chandra Adhikari

  • CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

    Jarem Edwards;James S. Wilmott;Jason Madore;Tuba Nur Gide

  • Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

    Celeste Lebbé;Nicolas Meyer;Laurent Mortier;Ivan Marquez-Rodas

  • sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

    Amanpreet Kaur;Amanpreet Kaur;Marie R. Webster;Katie Marchbank;Reeti Behera

  • Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma

    Georgina V. Long;Carina Fung;Alexander M. Menzies;Gulietta M. Pupo

  • Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

    M.H. Pollack;M.H. Pollack;A. Betof;H. Dearden;K. Rapazzo;K. Rapazzo

  • Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.

    Douglas B. Johnson;Alexander M. Menzies;Lisa Zimmer;Zeynep Eroglu

  • Immune checkpoint inhibitors in challenging populations

    Douglas B. Johnson;Ryan J. Sullivan;Alexander M. Menzies

  • Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

    Alexander M. Menzies;Alexander M. Menzies;Rodabe N. Amaria;Elisa A. Rozeman;Alexander C. Huang

Frequent Co-Authors

Georgina V. Long
Georgina V. Long University of Sydney
Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Matteo S. Carlino
Matteo S. Carlino University of Sydney
Richard F. Kefford
Richard F. Kefford Macquarie University
John F. Thompson
John F. Thompson University of Sydney
Douglas B. Johnson
Douglas B. Johnson Vanderbilt University Medical Center
Helen Rizos
Helen Rizos Macquarie University
James S. Wilmott
James S. Wilmott University of Sydney
Christian U. Blank
Christian U. Blank Antoni van Leeuwenhoek Hospital
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA doesn’t always mean traditional medical school. There are diverse online nursing and healthcare degrees that can offer flexible, affordable, and rewarding career pathways.

For those aiming to advance in nursing, phd nursing programs online offer new avenues for leadership, research, and education. If you are a registered nurse seeking to boost your qualifications, choosing from the cheapest online rn to bsn programs can help you progress your career without heavy student debt.

Not from a nursing background? Consider online direct entry msn programs for non-nursing majors. These programs let non-nurses transition to advanced nursing roles in less time through flexible online learning.

If gaining admission is your concern, exploring the easiest nursing schools to get into can help identify more accessible entry points for a fulfilling career in healthcare.

Best Scientists Citing Alexander M. Menzies

Trending Scientists

Recently Published Articles